Prognostic value of an integrated immune-inflammatory phenotype in surgically treated cervical cancer: survival modeling and immunohistochemical validation - Top-Institutions - MDSpire

Prognostic value of an integrated immune-inflammatory phenotype in surgically treated cervical cancer: survival modeling and immunohistochemical validation

  • By

  • Lin Ran

  • Zhaoan Lian

  • Yong Tian

  • Li Qin

  • Yingchun Xiang

  • Xiaohao Yan

  • Chengyu Shui

  • June 16, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology
    • Gynecologic Oncology

  • #2

    National University Hospital of Singapore
    National University Hospital of Singapore

    Singapore, Singapore

    Key Differentiators

    • Oncology

  • #3

    Medical University of Vienna
    Medical University of Vienna

    Vienna, Austria

    Key Differentiators

    • Oncology

  • #4

    University Hospital Mútua Terrassa
    University Hospital Mútua Terrassa

    Terrassa, Spain

    Key Differentiators

    • Oncology

  • #5

    Institute of Pathology, Klinikum Bayreuth GmbH
    Institute of Pathology, Klinikum Bayreuth GmbH

    Bayreuth, Germany

    Key Differentiators

    • Pathology
    • Oncology

Original Source(s)

Prognostic value of an integrated immune-inflammatory phenotype in surgically treated cervical cancer: survival modeling and immunohistochemical validation

  • by Lin Ran, Zhaoan Lian, Yong Tian, Li Qin, Yingchun Xiang, Xiaohao Yan, Chengyu Shui

  • June 16, 2026

Related Content

Adjuvant Chemoradiotherapy or Chemotherapy After D2 Gastrectomy in Gastric Cancer: A Randomized Clinical Trial

Meningeal immunity and “Interstitial” therapy: a new paradigm for immunotherapy in glioblastoma

Correction: miR-17: from developmental regulatory hub to molecular engine driving tumourigenesis